Suchergebnisse - (Person:"Mo, Hongnan")

PubPharm (2)

1

Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody

enthalten in: Thoracic cancer | 2019

von Wang, X. | Zhang, B. | Chen, X. | +6

2

Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China

enthalten in: Cancer | 2019

von Huang, J. | Mo, H. | Zhang, W. | +12

1
[1]